4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-058002
EVP, Research & CSO sold 2,340 shares at $26.26 ($61,448)
- EVP, Research & CSO acquired 2,340 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-11-10 | Option exercise | +2,340 | $1.53 | $3,580 | 26,040 | D |
| Virgin Herbert EVP, Research & CSO | 2020-11-10 | Sale | −2,340 | $26.26 | $61,448 | 23,700 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-11-10 | Option exercise · Stock Option (Right to Buy) | −2,340 | 448,170 | D | ||
| Open-market sales · 2,340 sh · avg $26.26 · $61,448 | |||||||
Loading xslF345X03/doc4.xml…